{"title":"Short-Term Efficacy and Safety of Camrelizumab-Based Treatment for Refractory or Metastatic Oesophageal Squamous Cell Carcinoma","authors":"Yuan Yuan","doi":"10.14744/ejmo.2023.42506","DOIUrl":null,"url":null,"abstract":"Objectives: To evaluate the shortterm efficacy and safety of camrelizumab in combination with apatinib for refractory or metastatic oesophageal squamous cell carcinoma","PeriodicalId":11831,"journal":{"name":"Eurasian Journal of Medicine and Oncology","volume":"6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eurasian Journal of Medicine and Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14744/ejmo.2023.42506","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: To evaluate the shortterm efficacy and safety of camrelizumab in combination with apatinib for refractory or metastatic oesophageal squamous cell carcinoma
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
